Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership

Yahoo Entertainment·September 22, 2026·1 min read

From the source

Twist Bioscience Corporation (NASDAQ:TWST) is on the cusp of gaining significant exposure to the rapidly evolving artificial intelligence (AI)-driven drug di...

The full text couldn't be loaded here (the source may require a subscription).

View original at Yahoo Entertainment

Keep reading

AT&T Is Automating Away Jobs—and Its Old Telecom EmpireWired — AI · 3h ago From Experimentation to Execution: Strategic AI Adoption and Clinical Data Harmonization in Life Sciences - Pharmaceutical Executivepharmexec.com · 3h ago OpenAI hires Patreon co-founder Sam Yam to lead a new Creator Product divisionThe Decoder · 3h ago Contributor: There's precedent for regulating AI. Look to nuclear power - Los Angeles Timeslatimes.com · 3h ago

Was this useful?